Ligand validation:2XXY

KAI: 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE

KAI is a Ligand Of Interest in 2XXY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XXY_KAI_C_900	59%	12%	0.158	0.942	1.72	2.33	2	6	3	0	100%	1
2XXY_KAI_B_900	51%	13%	0.177	0.93	1.75	2.25	2	5	3	0	100%	1
2XXY_KAI_A_900	26%	12%	0.253	0.894	1.83	2.26	2	5	2	0	100%	1
2XXY_KAI_D_900	25%	12%	0.245	0.88	1.75	2.31	2	5	3	0	100%	1
4BDR_KAI_B_900	96%	17%	0.063	0.969	1.68	1.94	2	7	1	0	100%	1
2XXV_KAI_B_900	95%	17%	0.073	0.976	1.61	2.02	1	5	0	0	100%	1
2XXT_KAI_B_900	92%	16%	0.078	0.969	1.67	2	1	5	1	0	100%	1
1TT1_KAI_B_999	80%	19%	0.127	0.975	2.46	1.04	5	-	0	0	100%	1
3C33_KAI_B_401	97%	13%	0.067	0.981	2.05	1.88	3	2	0	0	100%	1
3C36_KAI_B_401	95%	15%	0.077	0.982	1.79	1.96	2	4	0	0	100%	1
5MFQ_KAI_B_901	93%	33%	0.084	0.98	1.31	1.35	1	2	0	0	100%	1
1XHY_KAI_A_1001	93%	19%	0.077	0.97	1.67	1.75	3	4	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.